Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Perrigo Company    PRGO

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2014 4 011 M
EBIT 2014 944 M
Net income 2014 422 M
Debt 2014 2 404 M
Yield 2014 0,22%
Sales 2015 5 515 M
EBIT 2015 1 441 M
Net income 2015 661 M
Debt 2015 3 958 M
Yield 2015 0,21%
PER 2014 66,98
PER 2015 43,72
EV / Sales 2014 7,60x
EV / Sales 2015 5,81x
Capitalization 28 093 M
More Financials
Company
Perrigo Co. plc is a global healthcare supplier.It develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, and active pharmaceutical ingredients.The company operates its business through following segments: Consumer Healthcare, Nutritionals,... 
Sector
Pharmaceuticals
Calendar
08/05 | 08:00amEarnings Release
More about the company
Surperformance© ratings of Perrigo Company
Trading Rating : Investor Rating :
More Ratings
Latest news on PERRIGO COMPANY
10:08a PERRIGO : Mylan gets European clearance in proposed Perrigo takeover
08:16aDJMylan Gets European Regulator's Approval for Perrigo Deal
07:51aDJMylan Gets European Regulator's Approval for Perrigo Deal
07/28 Hikma to buy Boehringer's U.S. generic drug business for $2.65 billion
07/27 Mylan independence from Teva's embrace comes with a price
07/27 Mylan independence from Teva's embrace comes with a price
07/27DJMylan's Leverage to Resist Teva Deal Reveals Shift in Rules
07/27 Teva drops bid for Mylan, buys Allergan's generics unit for $40.5 billion
More news
Sector news : Pharmaceuticals - NEC
09:53p Kyowa Hakko Kirin, Bristol-Myers Announce Immuno-Oncology Clinical Collaborat..
07:01p BRISTOL MYERS SQUIBB : Kyowa Hakko Kirin and Bristol-Myers Squibb Announce Immun..
05:06pDJVERTEX PHARMACEUTICALS : Revenue Rises 20%
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions